Earnings Release • Jul 19, 2010
Earnings Release
Open in ViewerOpens in native device viewer
Q2 2010, Royal Philips Electronics
"In Q2, Philips delivered anotherstrong quarter, with good top-line growth and strong profitability in all three operating sectors. Sales performance was especially strong in emerging markets. We are particularly pleased to have reached an adjusted profitability level of 10% in the quarter.
It is encouraging to see that our performance continues to improve, despite ongoing weakness in many global markets and economic uncertainty – a clear testimony to the soundness of our strategy and the strength of our portfolio. I believe we remain well on our way to becoming the leading company in health and well-being and consider this quarter another clear step in the right direction."
Gerard Kleisterlee, President and CEO of Royal Philips Electronics
This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items, in particular the paragraphs "Looking ahead" and "Outlook". Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements. These factors include but are not limited to domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2009 and the "Risk and uncertainties" section in our semi-annual financial report for the six months ended July 4, 2010.
Statements regarding market share, including those regarding Philips' competitive position, contained in this document are based on outside sourcessuch asresearch institutes, industry and dealer panelsin combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
In presenting and discussing the Philips Group's financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of such measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2009.
In presenting the Philips Group's financial position, fair-values are used for the measurement of various items in accordance with the applicable accounting standards. These fairvalues are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data do not exist, we estimated the fairvalues using appropriate valuation models and unobservable inputs. They require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our 2009 financial statements. Independent valuations may have been obtained to support management's determination of fairvalues.
All amounts in millions of euros unless otherwise stated; data included are unaudited. Financial reporting is in accordance with IFRS, unless otherwise stated. This document comprises regulated information within the meaning of the Dutch Financial Markets Supervision Act 'Wet op het Financieel Toezicht'.
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 5,230 | 6,191 |
| EBITA | 118 | 527 |
| as a % of sales | 2.3 | 8.5 |
| EBIT | 8 | 404 |
| as a % of sales | 0.2 | 6.5 |
| Financial expenses | (3) | (71) |
| Income taxes | 15 | (82) |
| Results investments in associates |
25 | 11 |
| Net income | 45 | 262 |
| Net income - shareholders per common share (in euros) - basic |
0.05 | 0.28 |
in millions of euros unless otherwise stated
| Q2 | Q2 | % change | ||
|---|---|---|---|---|
| 2009 | 2010 | nominal comparable | ||
| Healthcare | 1,872 | 2,068 | 10 | 4 |
| Consumer Lifestyle |
1,735 | 2,183 | 26 | 20 |
| Lighting | 1,550 | 1,859 | 20 | 13 |
| GM&S | 73 | 81 | 11 | 11 |
| Philips Group | 5,230 | 6,191 | 18 | 12 |
in millions of euros unless otherwise stated
| Q21) | Q2 | % change | ||
|---|---|---|---|---|
| 2009 | 2010 | nominal comparable | ||
| Western Europe | 1,803 | 1,986 | 10 | 8 |
| North America | 1,633 | 1,745 | 7 | 0 |
| Other mature markets | 290 | 370 | 28 | 12 |
| Total mature markets | 3,726 | 4,101 | 10 | 5 |
| Emerging markets | 1,504 | 2,090 | 39 | 29 |
| Philips Group | 5,230 | 6,191 | 18 | 12 |
1) Revised to reflect an adjusted market cluster allocation
in millions of euros
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 153 | 216 |
| Consumer Lifestyle | (7) | 173 |
| Lighting | (21) | 210 |
| Group Management & Services |
(7) | (72) |
| Philips Group | 118 | 527 |
as a % of sales
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 8.2 | 10.4 |
| Consumer Lifestyle | (0.4) | 7.9 |
| Lighting | (1.4) | 11.3 |
| Group Management & Services |
(9.6) | (88.9) |
| Philips Group | 2.3 | 8.5 |
in millions of euros
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | (24) | (46) |
| Consumer Lifestyle | (30) | (10) |
| Lighting | (82) | (37) |
| Group Management & Services |
(12) | − |
| Philips Group | (148) | (93) |
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 88 | 148 |
| Consumer Lifestyle | (12) | 164 |
| Lighting | (61) | 166 |
| Group Management & Services |
(7) | (74) |
| Philips Group | 8 | 404 |
| as a % of sales | 0.2 | 6.5 |
| in millions of euros | ||
|---|---|---|
| Q2 | Q2 | |
| 2009 | 2010 | |
| Net interest expenses | (57) | (64) |
| Sale of Pace shares | 48 | − |
| TPV option fair value adjustment |
14 | (12) |
| Other | (8) | 5 |
| (3) | (71) | |
in millions of euros
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| TPV value adjustment | 25 | − |
| Other | − | 11 |
| 25 | 11 |
| in millions of euros | ||
|---|---|---|
| Q2 | Q2 | |
| 2009 | 2010 | |
| Beginning cash balance | 4,000 | 4,388 |
| Free cash flow | 251 | 348 |
| Net cash flow from operating activities |
446 | 562 |
| Net capital expenditures | (195) | (214) |
| Acquisitions of businesses | (55) | (21) |
| Other cash flow from investing activities |
65 | (15) |
| Treasury shares transactions |
6 | 19 |
| Changes in debt/other | (44) | 70 |
| Dividend paid | (634) | (296) |
| Ending cash balance | 3,589 | 4,493 |
in millions of euros
in millions of euros
1) Capital expenditures on property, plant and equipment only
• Operating activities led to a cash inflow of EUR 562 million, compared to an inflow of EUR 446 million in Q2 2009. The year-on-year increase was driven by higher earnings, partly offset by lower working capital inflow.
• Gross capital expenditures on property, plant and equipment were EUR 27 million higher than in Q2 2009, due to higher investments, mainly at Lighting and Healthcare.
as a % of moving annual total sales
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 1,872 | 2,068 |
| Sales growth | ||
| % nominal | 4 | 10 |
| % comparable | (5) | 4 |
| EBITA | 153 | 216 |
| as a % of sales | 8.2 | 10.4 |
| EBIT | 88 | 148 |
| as a % of sales | 4.7 | 7.2 |
| Net operating capital (NOC) | 8,738 | 9,545 |
| Number of employees (FTEs) | 35,094 | 34,344 |
in millions of euros
EBITA
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 1,735 | 2,183 |
| of which Television | 587 | 846 |
| Sales growth | ||
| % nominal | (36) | 26 |
| % comparable | (30) | 20 |
| Sales growth excl. Television | ||
| % nominal | (20) | 16 |
| % comparable | (19) | 6 |
| EBITA | (7) | 173 |
| of which Television | (99) | (8) |
| as a % of sales | (0.4) | 7.9 |
| EBIT | (12) | 164 |
| of which Television | (99) | (9) |
| as a % of sales | (0.7) | 7.5 |
| Net operating capital (NOC) | 903 | 1,055 |
| of which Television | (338) | (266) |
| Number of employees (FTEs) | 17,018 | 18,408 |
| of which Television | 4,955 | 4,519 |
in millions of euros
3,750
EBITA
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 1,550 | 1,859 |
| Sales growth | ||
| % nominal | (14) | 20 |
| % comparable | (18) | 13 |
| EBITA | (21) | 210 |
| as a % of sales | (1.4) | 11.3 |
| EBIT | (61) | 166 |
| as a % of sales | (3.9) | 8.9 |
| Net operating capital (NOC) | 5,676 | 5,934 |
| Number of employees (FTEs) | 51,627 | 52,031 |
in millions of euros
EBITA
• Restructuring and acquisition-related charges in Q3 2010 are expected to total around EUR 40 million.
in millions of euros unless otherwise stated
| Q2 | Q2 | |
|---|---|---|
| 2009 | 2010 | |
| Sales | 73 | 81 |
| Sales growth | ||
| % nominal | (47) | 11 |
| % comparable | (46) | 11 |
| EBITA Corporate Technologies | (44) | (22) |
| EBITA Corporate & Regional Costs | (30) | (35) |
| EBITA Pensions | 23 | (9) |
| EBITA Service Units and Other | 44 | (6) |
| EBITA | (7) | (72) |
| EBIT | (7) | (74) |
| Net operating capital (NOC) | (3,513) | (2,451) |
| Number of employees (FTEs) | 12,284 | 11,807 |
150
in millions of euros
in millions of euros
After the strong rebound in the first half of the year, we expect comparable sales growth in the remainder of the year to moderate towards mid-single-digit level. This reflects continued but slow recovery in the US and Europe, different seasonality for our Television business following soccer's World Cup, and the improved sales performance in the second half of 2009.
We will continue to drive further improvements, including, where necessary, taking the required actions to offset the effects of rising commodity and component prices. Having achieved an EBITA before restructuring and acquisition-related charges of 9.9% in the first halfyear, and assuming that the current economic climate will continue, we are confident that we can exceed 10% for the full-year 2010.
At our Capital Markets Day in London on September 14 we will update the markets on the medium-term prospects for our businesses in the context of our Vision 2015 plan.
Amsterdam, July 19, 2010 Board of Management
Introduction
This report contains the semi-annual financial report of Koninklijke Philips Electronics N.V. ('the Company'), a company with limited liability, headquartered in Amsterdam, the Netherlands. The principal activities of the Company and its group companies (the Philips Group) are described in note 4.
The semi-annual financial report for the six months ended July 4, 2010 consists of the condensed consolidated semiannual financial statements, the semi-annual management report and responsibility statement by the Company's Board of Management. The information in this semiannual financial report is unaudited.
The condensed consolidated semi-annual financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's consolidated IFRS financial statements for the year ended December 31, 2009.
The Board of Management of the Company hereby declares that to the best of their knowledge, the semiannual financial statements, which have been prepared in accordance with the applicable financial reporting standards for interim financial reporting, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole, and the semi-annual management report gives a fair review of the information required pursuant to section 5:25d(8)/(9) of the Dutch Financial Markets Supervision Act (Wet op het Financieel toezicht).
Amsterdam, July 19, 2010
in millions of euros unless otherwise stated
| January-June | ||
|---|---|---|
| 2009 | 2010 | |
| Sales | 10,305 | 11,868 |
| EBITA | 44 | 1,031 |
| as a % of sales | 0.4 | 8.7 |
| EBIT | (178) | 793 |
| as a % of sales | (1.7) | 6.7 |
| Financial expenses | (44) | (140) |
| Income taxes | 186 | (208) |
| Results investments in associates |
24 | 18 |
| Net income (loss) | (12) | 463 |
| Net income (loss) - shareholders per common |
||
| share (in euros) - basic | (0.02) | 0.49 |
in millions of euros unless otherwise stated
| January-June | % change | |||
|---|---|---|---|---|
| 2009 | 2010 | nominal comparable | ||
| Healthcare | 3,613 | 3,889 | 8 | 5 |
| Consumer Lifestyle |
3,491 | 4,125 | 18 | 15 |
| Lighting | 3,054 | 3,669 | 20 | 15 |
| GM&S | 147 | 185 | 26 | 30 |
| Philips Group | 10,305 | 11,868 | 15 | 12 |
in millions of euros
| January-June | |
|---|---|
| 2009 | 2010 |
| 221 | 382 |
| (56) | 339 |
| (16) | 455 |
| (145) | |
| 44 | 1,031 |
| (105) |
as a % of sales
| January-June | ||
|---|---|---|
| 2009 | 2010 | |
| Healthcare | 6.1 | 9.8 |
| Consumer Lifestyle | (1.6) | 8.2 |
| Lighting | (0.5) | 12.4 |
| Group Management & | ||
| Services | (71.4) | (78.4) |
| Philips Group | 0.4 | 8.7 |
• EBITA declined EUR 40 million compared to the first half of 2009, as last year's results were favorably impacted by EUR 57 million insurance recoveries and a EUR 33 million legal settlement. Excluding those items, EBITA increased by EUR 50 million year-on-year, driven by higher revenue from licenses and lower R&D costs.
In our Annual Report 2009 we have extensively described certain risk categories and risk factors which could have a material adverse effect on our financial position and results. Those risk categories and risk factors are deemed incorporated and repeated in this report by reference.
For the remainder of 2010, we see the risk of growth stagnation due to government deficits in our markets, in particular in our activities that cater to the consumer markets and the healthcare market.
Additional risks not known to us, or currently believed not to be material, could later turn out to have a material impact on our businesses, objectives, revenues, income, assets, liquidity or capital resources.
all amounts in millions of euros unless otherwise stated
| 2nd quarter | January-June | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Sales | 5,230 | 6,191 | 10,305 | 11,868 |
| Cost of sales | (3,455) | (3,910) | (6,900) | (7,409) |
| Gross margin | 1,775 | 2,281 | 3,405 | 4,459 |
| Selling expenses | (1,209) | (1,265) | (2,414) | (2,488) |
| General and administrative expenses | (211) | (231) | (424) | (425) |
| Research and development expenses | (384) | (398) | (790) | (773) |
| Other business income | 56 | 17 | 64 | 27 |
| Other business expenses | (19) | − | (19) | (7) |
| Income (loss) from operations | 8 | 404 | (178) | 793 |
| Financial income | 76 | 17 | 173 | 28 |
| Financial expenses | (79) | (88) | (217) | (168) |
| Income (loss) before taxes | 5 | 333 | (222) | 653 |
| Income taxes | 15 | (82) | 186 | (208) |
| Income (loss) after taxes | 20 | 251 | (36) | 445 |
| Results relating to investments in associates | 25 | 11 | 24 | 18 |
| Net income (loss) for the period | 45 | 262 | (12) | 463 |
| Attribution of net income for the period | ||||
| Net income (loss) attributable to shareholders | 44 | 259 | (15) | 459 |
| Net income attributable to non-controlling interests | 1 | 3 | 3 | 4 |
| Weighted average number of common shares outstanding (after deduction of treasury shares) during the period (in thousands): |
||||
| - basic | 925,244 | 939,690 | 924,271 | 933,714 |
| - diluted | 927,918 | 948,708 | 926,413 | 941,817 |
| Net income (loss) attributable to shareholders | ||||
| per common share in euros: | ||||
| - basic | 0.05 | 0.28 | (0.02) | 0.49 |
| - diluted1) | 0.05 | 0.27 | (0.02) | 0.49 |
| Ratios | ||||
| Gross margin as a % of sales | 33.9 | 36.8 | 33.0 | 37.6 |
| Selling expenses as a % of sales | (23.1) | (20.4) | (23.4) | (21.0) |
| G&A expenses as a % of sales | (4.0) | (3.7) | (4.1) | (3.6) |
| R&D expenses as a % of sales | (7.3) | (6.4) | (7.7) | (6.5) |
| EBIT | 8 | 404 | (178) | 793 |
| as a % of sales | 0.2 | 6.5 | (1.7) | 6.7 |
| EBITA | 118 | 527 | 44 | 1,031 |
| as a % of sales | 2.3 | 8.5 | 0.4 | 8.7 |
1) the incremental shares from assumed conversion are not taken into account in the periods for which there is a loss attributable to shareholders, as the effect would be antidilutive.
all amounts in millions of euros
| 2nd quarter | January-June | |||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |||
| Net income (loss) for the period: | 45 | 262 | (12) | 463 | ||
| Other comprehensive income: | ||||||
| Actuarial losses on pension plans: | ||||||
| Net current period change, before tax | (2,377) | − | (2,381) | − | ||
| Income tax on net current period change | 613 | − | 613 | (4) | ||
| Revaluation reserve: | ||||||
| Release revaluation reserve | (2) | (4) | (6) | (8) | ||
| Reclassification into retained earnings | 2 | 4 | 6 | 8 | ||
| Currency translation differences: | ||||||
| Net current period change, before tax | (135) | 568 | 58 | 954 | ||
| Income tax on net current period change | − | (5) | (1) | (9) | ||
| Reclassification into loss | − | − | − | (2) | ||
| Available-for-sale securities: | ||||||
| Net current period change | 55 | (47) | 204 | 1 | ||
| Reclassification into income | (51) | (4) | (123) | (4) | ||
| Cash flow hedges: | ||||||
| Net current period change, before tax | (8) | (34) | (18) | (44) | ||
| Income tax on net current period change | (5) | 9 | (14) | 11 | ||
| Reclassification into (income) loss | 29 | (1) | 55 | (4) | ||
| Other comprehensive income for the period | (1,879) | 486 | (1,607) | 899 | ||
| Total comprehensive income for the period | (1,834) | 748 | (1,619) | 1,362 | ||
| Total comprehensive income attributable to: | ||||||
| Shareholders | (1,835) | 745 | (1,622) | 1,358 | ||
| Non-controlling interests | 1 | 3 | 3 | 4 |
in millions of euros unless otherwise stated
| June 28, | December 31, | July 4, | |
|---|---|---|---|
| 2009 | 2009 | 2010 | |
| Non-current assets: | |||
| Property, plant and equipment | 3,423 | 3,252 | 3,430 |
| Goodwill | 7,449 | 7,362 | 8,589 |
| Intangible assets excluding goodwill | 4,358 | 4,161 | 4,612 |
| Non-current receivables | 80 | 85 | 104 |
| Investments in associates | 245 | 281 | 191 |
| Other non-current financial assets | 822 | 691 | 764 |
| Deferred tax assets | 1,365 | 1,243 | 1,390 |
| Other non-current assets | 59 | 1,543 | 1,714 |
| Total non-current assets | 17,801 | 18,618 | 20,794 |
| Current assets: | |||
| Inventories | 3,330 | 2,913 | 3,928 |
| Other current financial assets | 125 | 191 | 195 |
| Other current assets | 518 | 436 | 636 |
| Receivables | 3,796 | 3,983 | 4,268 |
| Cash and cash equivalents | 3,589 | 4,386 | 4,493 |
| Total current assets | 11,358 | 11,909 | 13,520 |
| Total assets | 29,159 | 30,527 | 34,314 |
| Shareholders' equity Non-controlling interests |
13,325 47 |
14,595 49 |
15,736 61 |
| Group equity | 13,372 | 14,644 | 15,797 |
| Non-current liabilities: | |||
| Long-term debt | 3,745 | 3,640 | 3,053 |
| Long-term provisions | 1,853 | 1,734 | 1,803 |
| Deferred tax liabilities | 149 | 530 | 519 |
| Other non-current liabilities | 1,943 | 1,929 | 2,307 |
| Total non-current liabilities | 7,690 | 7,833 | 7,682 |
| Current liabilities: | |||
| Short-term debt | 684 | 627 | 1,746 |
| Accounts and notes payable | 2,560 | 2,870 | 3,462 |
| Accrued liabilities | 3,217 | 3,134 | 4,132 |
| Short-term provisions | 1,057 | 716 | 732 |
| Other current liabilities | 579 | 703 | 763 |
| Total current liabilities | 8,097 | 8,050 | 10,835 |
| Total liabilities and group equity | 29,159 | 30,527 | 34,314 |
| Number of common shares outstanding (after deduction of treasury shares) at the end of period (in thousands) |
926,041 | 927,457 | 945,312 |
| Ratios | |||
| Shareholders' equity per common share in euros | 14.39 | 15.74 | 16.65 |
| Inventories as a % of sales | 13.7 | 12.6 | 15.9 |
| Net debt : group equity | 6:94 | (1):101 | 2:98 |
| Net operating capital | 11,804 | 12,649 | 14,083 |
| Employees at end of period | 116,023 | 115,924 | 116,590 |
all amounts in millions of euros
| 2nd quarter | January to June | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Cash flows from operating activities: | ||||
| Net income (loss) | 45 | 262 | (12) | 463 |
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||
| Depreciation and amortization | 346 | 349 | 678 | 687 |
| Impairment of other non-current financial assets and (reversal of) impairment of investments in associates | (25) | 4 | 24 | 4 |
| Net gain on sale of assets | (51) | (12) | (124) | (18) |
| Income from investments in associates | − | (14) | (1) | (16) |
| Dividends received from investments in associates | 5 | 5 | 34 | 13 |
| Decrease (increase) in working capital: | 229 | 132 | (96) | (220) |
| Decrease (increase) in receivables and other current assets | 98 | (127) | 621 | (35) |
| Decrease (increase) in inventories | 130 | (354) | 232 | (593) |
| Increase (decrease) in accounts payable, accrued and other liabilities | 1 | 613 | (949) | 408 |
| Increase in non-current receivables/other assets/other liabilities | (123) | (57) | (402) | (144) |
| Increase (decrease) in provisions | 32 | (29) | 25 | (71) |
| Other items | (12) | (78) | 14 | (108) |
| Net cash (used for) provided by operating activities | 446 | 562 | 140 | 590 |
| Cash flows from investing activities: | ||||
| Purchase of intangible assets | (22) | (18) | (45) | (26) |
| Expenditures on development assets | (52) | (55) | (86) | (109) |
| Capital expenditures on property, plant and equipment | (140) | (167) | (252) | (305) |
| Proceeds from disposals of property, plant and equipment | 19 | 26 | 27 | 47 |
| Cash from (to) derivatives and securities | (12) | (20) | (10) | (42) |
| Purchase of other non-current financial assets | − | (6) | (6) | (12) |
| Proceeds from other non-current financial assets | 77 | 11 | 706 | 14 |
| Purchase of businesses, net of cash acquired | (55) | (21) | (90) | (24) |
| Proceeds from sale of interests in businesses | − | − | − | 98 |
| Net cash provided by (used for) investing activities | (185) | (250) | 244 | (359) |
| Cash flows from financing activities: | ||||
| Decrease (increase) in short-term debt | (59) | 11 | (98) | 23 |
| Principal payments on long-term debt | (13) | (23) | (24) | (37) |
| Proceeds from issuance of long-term debt | 26 | 19 | 289 | 29 |
| Treasury shares transactions | 6 | 19 | 15 | 43 |
| Dividend paid | (634) | (296) | (634) | (296) |
| Net cash provided by financing activities | (674) | (270) | (452) | (238) |
| Net increase (decrease) in cash and cash equivalents | (413) | 42 | (68) | (7) |
| Effect of change in exchange rates on cash positions | 2 | 63 | 37 | 114 |
| Cash and cash equivalents at beginning of period | 4,000 | 4,388 | 3,620 | 4,386 |
| Cash and cash equivalents at end of period | 3,589 | 4,493 | 3,589 | 4,493 |
| Ratio | ||||
| Cash flows before financing activities | 261 | 312 | 384 | 231 |
| Net cash paid during the period for | ||||
| Pensions | (98) | (105) | (204) | (220) |
| Interest | (62) | (62) | (136) | (138) |
| Income taxes | (34) | (47) | (108) | (108) |
For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the
in millions of euros
| January to June 2010 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other reserves | ||||||||||||
| com mon shares |
capital in ex cess of par val ue |
re tained earn ings |
revalu ation re serve |
curren cy transla tion dif feren ces |
unreal ized gain (loss) on available for-sale financial assets |
changes in fair value of cash flow hedges |
total | treas ury shares at cost |
total share hold ers' equity |
non con trolling inter ests |
total equity |
|
| January-June 2010 | ||||||||||||
| Balance as of December 31, 2009 | 194 | − | 15,947 | 102 | (591) | 120 | 10 | (461) | (1,187) | 14,595 | 49 | 14,644 |
| Total comprehensive income | 463 | (8) | 943 | (3) | (37) | 903 | 1,358 | 4 | 1,362 | |||
| Dividend distributed | 3 | 343 | (650) | (304) | (304) | |||||||
| Non-controlling interest movement | 8 | 8 | ||||||||||
| Re-issuance of treasury shares | (46) | 8 | 86 | 48 | 48 | |||||||
| Share-based compensation plans | 29 | 29 | 29 | |||||||||
| Income tax share-based compensation plans |
10 | 10 | 10 | |||||||||
| 3 | 336 | (642) | 86 | (217) | 8 | (209) | ||||||
| Balance as of July 4, 2010 | 197 | 336 | 15,768 | 94 | 352 | 117 | (27) | 442 | (1,101) | 15,736 | 61 | 15,797 |
| January-June 2009 | ||||||||||||
| Balance as of December 31, 2008 | 194 | − | 17,101 | 117 | (527) | (25) | (28) | (580) | (1,288) | 15,544 | 49 | 15,593 |
| Total comprehensive income | (1,777) | (6) | 57 | 81 | 23 | 161 | (1,622) | 3 | (1,619) | |||
| Dividend distributed | (647) | (647) | (647) | |||||||||
| Non-controlling interest movement | (5) | (5) | ||||||||||
| Re-issuance of treasury shares | (35) | (21) | 71 | 15 | 15 | |||||||
| Share-based compensation plans | 35 | 35 | 35 | |||||||||
| − | (668) | 71 | (597) | (5) | (602) | |||||||
| Balance as of June 28, 2009 | 194 | − | 14,656 | 111 | (470) | 56 | (5) | (419) | (1,217) | 13,325 | 47 | 13,372 |
all amounts in millions of euros unless otherwise stated
| 2nd quarter | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||||
| Sales including inter company |
sales | income from operations | Sales including inter company |
sales | income from operations | |||
| amount | as a % of sales |
amount | as a % of sales |
|||||
| Healthcare | 1,873 | 1,872 | 88 | 4.7 | 2,072 | 2,068 | 148 | 7.2 |
| Consumer Lifestyle* | 1,739 | 1,735 | (12) | (0.7) | 2,188 | 2,183 | 164 | 7.5 |
| Lighting | 1,552 | 1,550 | (61) | (3.9) | 1,864 | 1,859 | 166 | 8.9 |
| Group Management & Services | 121 | 73 | (7) | (9.6) | 123 | 81 | (74) | (91.4) |
| Inter-sector eliminations | (55) | (56) | ||||||
| 5,230 | 5,230 | 8 | 0.2 | 6,191 | 6,191 | 404 | 6.5 | |
| * of which Television | 588 | 587 | (99) | (16.9) | 848 | 846 | (9) | (1.1) |
| January to June | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||||
| Sales including inter company |
sales | income from operations | Sales including inter company |
sales | income from operations | |||
| amount | as a % of sales |
amount | as a % of sales |
|||||
| Healthcare | 3,616 | 3,613 | 89 | 2.5 | 3,896 | 3,889 | 251 | 6.5 |
| Consumer Lifestyle* | 3,500 | 3,491 | (65) | (1.9) | 4,134 | 4,125 | 321 | 7.8 |
| Lighting | 3,058 | 3,054 | (97) | (3.2) | 3,676 | 3,669 | 370 | 10.1 |
| Group Management & Services | 238 | 147 | (105) | (71.4) | 265 | 185 | (149) | (80.5) |
| Inter-sector eliminations | (107) | (103) | ||||||
| 10,305 | 10,305 | (178) | (1.7) | 11,868 | 11,868 | 793 | 6.7 | |
| * of which Television | 1,270 | 1,270 | (182) | (14.3) | 1,550 | 1,546 | (29) | (1.9) |
in millions of euros
| sales | total assets | |||
|---|---|---|---|---|
| January to June | June 28, | July 4, | ||
| 2009 | 2010 | 2009 | 2010 | |
| Healthcare | 3,613 | 3,889 | 11,297 | 12,550 |
| Consumer Lifestyle | 3,491 | 4,125 | 3,137 | 3,904 |
| Lighting | 3,054 | 3,669 | 7,100 | 7,766 |
| Group Management & Services | 147 | 185 | 7,625 | 10,094 |
| 10,305 | 11,868 | 29,159 | 34,314 |
| sales | long-lived assets1) | |||
|---|---|---|---|---|
| January to June | June 28, | July 4, | ||
| 20092) | 2010 | 20092) | 2010 | |
| Netherlands | 400 | 399 | 1,264 | 1,206 |
| United States | 3,003 | 3,061 | 10,154 | 11,007 |
| China | 787 | 952 | 362 | 452 |
| Germany | 834 | 928 | 289 | 286 |
| France | 650 | 693 | 132 | 117 |
| Brazil | 354 | 555 | 114 | 140 |
| Japan | 304 | 423 | 448 | 605 |
| Other countries | 3,973 | 4,857 | 2,467 | 2,818 |
| 10,305 | 11,868 | 15,230 | 16,631 |
1) Includes property, plant and equipment, intangible assets excluding goodwill, and goodwill
2) Revised to reflect an adjusted country allocation
in millions of euros
| 2nd quarter | ||||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Costs of defined-benefit plans (pensions) | ||||||
| Service cost | 27 | 22 | 49 | 23 | 21 | 44 |
| Interest cost on the defined-benefit obligation | 133 | 100 | 233 | 131 | 110 | 241 |
| Expected return on plan assets | (189) | (86) | (275) | (186) | (93) | (279) |
| Prior service cost | − | 1 | 1 | − | (1) | (1) |
| Net periodic cost (income) | (29) | 37 | 8 | (32) | 37 | 5 |
| Costs of defined-contribution plans | ||||||
| Costs | 1 | 29 | 30 | 2 | 29 | 31 |
| Total | 1 | 29 | 30 | 2 | 29 | 31 |
| Costs of defined-benefit plans (retiree medical) |
||||||
| Service cost | − | 1 | 1 | − | − | − |
| Interest cost on the defined-benefit obligation | − | 9 | 9 | − | 6 | 6 |
| Prior service cost | − | − | − | − | (1) | (1) |
| Net periodic cost | − | 10 | 10 | − | 5 | 5 |
| January to June | ||||||
|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||
| Netherlands | other | total | Netherlands | other | total | |
| Costs of defined-benefit plans (pensions) | ||||||
| Service cost | 54 | 44 | 98 | 46 | 39 | 85 |
| Interest cost on the defined-benefit obligation | 266 | 201 | 467 | 261 | 211 | 472 |
| Expected return on plan assets | (379) | (173) | (552) | (372) | (176) | (548) |
| Prior service cost | − | 2 | 2 | − | (1) | (1) |
| Net periodic cost (income) | (59) | 74 | 15 | (65) | 73 | 8 |
| Costs of defined-contribution plans | ||||||
| Costs | 3 | 53 | 56 | 4 | 58 | 62 |
| Total | 3 | 53 | 56 | 4 | 58 | 62 |
| Costs of defined-benefit plans (retiree medical) |
||||||
| Service cost | − | 1 | 1 | − | 1 | 1 |
| Interest cost on the defined-benefit obligation | − | 18 | 18 | − | 11 | 11 |
| Prior service cost | − | − | − | − | (2) | (2) |
| Net periodic cost | − | 19 | 19 | − | 10 | 10 |
all amounts in millions of euros unless otherwise stated.
Certain non-GAAP financial measures are presented when discussing the Philips Group's performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
| 2nd quarter | January to June | |||||||
|---|---|---|---|---|---|---|---|---|
| comparable growth |
currency effects |
consolid ation changes |
nominal growth |
comparable growth |
currency effects |
consolid ation changes |
nominal growth |
|
| 2010 versus 2009 | ||||||||
| Healthcare | 4.1 | 6.5 | (0.1) | 10.5 | 5.3 | 2.4 | (0.1) | 7.6 |
| Consumer Lifestyle | 19.6 | 6.5 | (0.3) | 25.8 | 15.2 | 3.7 | (0.7) | 18.2 |
| Lighting | 12.9 | 6.9 | 0.1 | 19.9 | 15.4 | 3.6 | 1.1 | 20.1 |
| GM&S | 11.2 | 5.9 | (6.1) | 11.0 | 29.8 | 3.2 | (7.1) | 25.9 |
| Philips Group | 11.9 | 6.6 | (0.1) | 18.4 | 12.0 | 3.2 | 0.0 | 15.2 |
| Philips Group | Healthcare | Consumer Lifestyle |
Lighting | GM&S |
|---|---|---|---|---|
| 1,031 | 382 | 339 | 455 | (145) |
| (238) | (131) | (18) | (85) | (4) |
| 793 | 251 | 321 | 370 | (149) |
| 44 | 221 | (56) | (16) | (105) |
| (222) | (132) | (9) | (81) | − |
| (178) | 89 | (65) | (97) | (105) |
1) Excluding amortization of software and product development
| June 28, | December 31, | July 4, | |
|---|---|---|---|
| 2009 | 2009 | 2010 | |
| Long-term debt | 3,745 | 3,640 | 3,053 |
| Short-term debt | 684 | 627 | 1,746 |
| Total debt | 4,429 | 4,267 | 4,799 |
| Cash and cash equivalents | 3,589 | 4,386 | 4,493 |
| Net debt (cash) (total debt less cash and cash equivalents) | 840 | (119) | 306 |
| Shareholders' equity | 13,325 | 14,595 | 15,736 |
| Non-controlling interests | 47 | 49 | 61 |
| Group equity | 13,372 | 14,644 | 15,797 |
| Net debt and group equity | 14,212 | 14,525 | 16,103 |
| Net debt divided by net debt and group equity (in %) | 6 | (1) | 2 |
| Group equity divided by net debt and group equity (in %) | 94 | 101 | 98 |
all amounts in millions of euros
| July 4, 2010 Net operating capital (NOC) 14,083 9,545 1,055 5,934 (2,451) Exclude liabilities comprised in NOC: - payables/liabilities 10,664 2,521 2,358 1,443 4,342 - intercompany accounts − 49 94 76 (219) - provisions 2,535 355 396 290 1,494 Include assets not comprised in NOC: - investments in associates 191 80 1 23 87 - other current financial assets 194 − − − 194 - other non-current financial assets 764 − − − 764 - deferred tax assets 1,390 − − − 1,390 - cash and cash equivalents 4,493 − − − 4,493 Total assets 34,314 12,550 3,904 7,766 10,094 December 31, 2009 Net operating capital (NOC) 12,649 8,434 625 5,104 (1,514) Exclude liabilities comprised in NOC: - payables/liabilities 8,636 2,115 2,155 1,247 3,119 - intercompany accounts − 32 85 62 (179) - provisions 2,450 317 420 324 1,389 Include assets not comprised in NOC: - investments in associates 281 71 1 11 198 - other current financial assets 191 − − − 191 - other non-current financial assets 691 − − − 691 - deferred tax assets 1,243 − − − 1,243 - cash and cash equivalents 4,386 − − − 4,386 30,527 10,969 3,286 6,748 9,524 Total assets June 28, 2009 Net operating capital (NOC) 11,804 8,738 903 5,676 (3,513) Exclude liabilities comprised in NOC: - payables/liabilities 8,299 2,133 1,872 1,116 3,178 - intercompany accounts − 48 59 44 (151) - provisions 2,910 305 301 251 2,053 Include assets not comprised in NOC: - investments in associates 245 73 2 13 157 - other current financial assets 125 − − − 125 - other non-current financial assets 822 − − − 822 - deferred tax assets 1,365 − − − 1,365 |
Philips Group | Healthcare | Consumer Lifestyle |
Lighting | GM&S | |
|---|---|---|---|---|---|---|
| 3,589 − − − 3,589 |
- cash and cash equivalents |
|||||
| Total assets 29,159 11,297 3,137 7,100 7,625 |
all amounts in millions of euros
| 2nd quarter | January to June | |||
|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | |
| Cash flows provided by operating activities | 446 | 562 | 140 | 590 |
| Cash flows (used for) provided by investing activities | (185) | (250) | 244 | (359) |
| Cash flows before financing activities | 261 | 312 | 384 | 231 |
| Cash flows provided by operating activities | 446 | 562 | 140 | 590 |
| Purchase of intangible assets | (22) | (18) | (45) | (26) |
| Expenditures on development assets | (52) | (55) | (86) | (109) |
| Capital expenditures on property, plant and equipment | (140) | (167) | (252) | (305) |
| Proceeds from disposals of property, plant and equipment | 19 | 26 | 27 | 47 |
| Net capital expenditures | (195) | (214) | (356) | (393) |
| Free cash flows | 251 | 348 | (216) | 197 |
all amounts in millions of euros unless otherwise stated
| 2009 | 2010 | |||||||
|---|---|---|---|---|---|---|---|---|
| 1st quarter |
2nd quarter |
3rd quarter |
4th quarter |
1st quarter |
2nd quarter |
3rd quarter |
4th quarter |
|
| Sales | 5,075 | 5,230 | 5,621 | 7,263 | 5,677 | 6,191 | ||
| % increase | (15) | (19) | (11) | (5) | 12 | 18 | ||
| EBITA | (74) | 118 | 344 | 662 | 504 | 527 | ||
| as a % of sales | (1.5) | 2.3 | 6.1 | 9.1 | 8.9 | 8.5 | ||
| EBIT | (186) | 8 | 237 | 555 | 389 | 404 | ||
| as a % of sales | (3.7) | 0.2 | 4.2 | 7.6 | 6.9 | 6.5 | ||
| Net income (loss) - shareholders | (59) | 44 | 174 | 251 | 200 | 259 | ||
| per common share in euros - basic | (0.06) | 0.05 | 0.19 | 0.27 | 0.22 | 0.28 | ||
| January March |
January June |
January September |
January December |
January March |
January June |
January September |
January December |
|
| Sales | 5,075 | 10,305 | 15,926 | 23,189 | 5,677 | 11,868 | ||
| % income | (15) | (17) | (15) | (12) | 12 | 15 | ||
| EBITA | (74) | 44 | 388 | 1,050 | 504 | 1,031 | ||
| as a % of sales | (1.5) | 0.4 | 2.4 | 4.5 | 8.9 | 8.7 |
| EBITA | (74) | 44 | 388 | 1,050 | 504 | 1,031 | |
|---|---|---|---|---|---|---|---|
| as a % of sales | (1.5) | 0.4 | 2.4 | 4.5 | 8.9 | 8.7 | |
| EBIT | (186) | (178) | 59 | 614 | 389 | 793 | |
| as a % of sales | (3.7) | (1.7) | 0.4 | 2.6 | 6.9 | 6.7 | |
| Net income (loss) - shareholders | (59) | (15) | 159 | 410 | 200 | 459 | |
| per common share in euros - basic | (0.06) | (0.02) | 0.17 | 0.44 | 0.22 | 0.49 | |
| Net income (loss) from continuing operations as a % of shareholders' equity |
(1.6) | (0.2) | 1.5 | 2.7 | 5.9 | 6.7 | |
| period ended 2009 | period ended 2010 | ||||||
| Inventories as a % of sales | 13.6 | 13.7 | 14.5 | 12.6 | 13.9 | 15.9 | |
| Net debt : group equity ratio | 3:97 | 6:94 | 4:96 | (1):101 | 1:99 | 2:98 | |
| Total employees (in thousands) | 116 | 116 | 118 | 116 | 116 | 117 | |
Information also available on Internet, address: www.philips.com/investorrelations
| 1 Significant accounting policies |
29 |
|---|---|
| Estimates 2 |
29 |
| Financial risk management 3 |
30 |
| Segment information 4 |
30 |
| Seasonality 5 |
30 |
| Acquisitions and divestments 6 |
30 |
| Investments in associates 7 |
30 |
| 8 Income taxes |
31 |
| Property, plant and equipment 9 |
31 |
| Goodwill 10 |
31 |
| Intangible assets excluding goodwill 11 |
32 |
| Other non-current financial assets 12 |
32 |
| Inventories 13 |
33 |
| Shareholders' equity 14 |
33 |
| 15 Short-term and long-term debt |
33 |
| Provisions 16 |
33 |
| Accrued liabilities 17 |
33 |
| Pensions 18 |
33 |
| Contingent liabilities 19 |
34 |
| Related-party transactions 20 |
35 |
| Share-based compensation 21 |
35 |
This report contains the semi-annual financial report of Koninklijke Philips Electronics N.V. ('the Company'), a company with limited liability, headquartered in Amsterdam, the Netherlands. The principal activities of the Company and its group companies (the Philips Group) are described in note 4.
The semi-annual financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union.
The significant accounting policies applied in these semiannual financial statements are consistent with those applied in the Company's consolidated IFRS financial statements for the year ended December 31, 2009, except for the adoption of the following new standards, amendmentsto standards and interpretations, which have been adopted as relevant to the Company for the first time:
On January 1, 2010, the Company applied IFRS 3 'Business Combinations' (revised standard 2008) in accounting for business combinations. This revised standard has been applied prospectively and since there were no significant acquisitions during the first half of 2010, the change did not have a material impact on the Company's consolidated financial statements.
For acquisitions on or after January 1, 2010, the Company measures goodwill as the fair value of the consideration transferred (including the fair value of any previously-held equity interest in the acquiree) and the recognised amount of any non-controlling interests in the acquiree, lessthe netrecognised amount (generally fair value) of the identifiable assets acquired and liabilities assumed, all measured as of the acquisition date. When the excess is negative, a bargain purchase gain is recognised immediately in the statements of income.
Transaction costs, other than those associated with the issue of debt or equity securities, that the Company incurs in connection with a business combination, are expensed as incurred.
Accounting for acquisitions of non-controlling interests From January 1, 2010, the Company has applied IAS 27 'Consolidated and Separate Financial Statements' (amendment 2008) in accounting for acquisitions of noncontrolling interests. The change in accounting policy has been applied prospectively; there was no impact on the Company's consolidated financial statements.
1 Significant accounting policies From January 1, 2010, acquisitions of non-controlling interests are accounted for as transactions with equity holders in their capacity as equity holders and therefore no goodwill is recognized. Previously, goodwill arising on the acquisition of non-controlling interests in a subsidiary was recognized and represented the excess of the cost of the additional investment over the carrying amount of the interest in the net assets acquired at the date of the transaction.
From January 1, 2010, the Company applied 'IFRIC 17 Distributions of Non-cash Assets to Owners' in accounting for distribution of non-cash assets to owners. This accounting policy has been applied prospectively and did not have a material impact on the Company's consolidated financial statements.
The Group measures a liability to distribute non-cash assets to owners as the fair value of the assets to be distributed. The carrying amount of the liability is measured at each reporting period and the settlement date, with any changesrecognized in equity as adjustments to the amount of the distribution.
Upon settlement of the transaction, the Company recognizes the difference, if any, between the carrying amount of the assets distributed and the carrying amount of the liability in the statements of income.
Other IFRS standards and interpretations effective from January 1, 2010 did not have a material impact on the Company.
The preparation of the semi-annual financial statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.
In preparing these condensed consolidated semi-annual financial statements, the significant estimates and judgments made by management in applying the Group's accounting policies and the key sources of estimation
uncertainty were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2009.
The Group's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 31 December 2009.
Philips' activities are organized on a sector basis, with operating sectors – Healthcare, Consumer Lifestyle and Lighting – each being responsible for the management of its business worldwide, and Group Management & Services (GM&S). A short description of these sectors is as follows:
Reportable segments for the purpose of the segmental disclosures required by IAS 34 Interim Financial Statements are: Healthcare, Consumer Lifestyle, Television and Lighting.
Significant segment information can be found in the Sectors, Sectors and main countries and Reconciliation of non-GAAP performance measures sections of this document.
3 Financial risk management 4 Segment information Under normal economic conditions, the Group's sales are impacted by seasonal fluctuations, particularly at Consumer Lifestyle and Healthcare, typically resulting in higher revenues and earnings in the second half-year results. Within Healthcare, sales are generally higher in the second half of the year, largely due to the timing of new product availability and customers attempting to spend their annual budgeted allowances before the end of the year. Within Consumer Lifestyle, sales are generally higher in the second half-year due to the holiday sales. Salesin the Lighting businesses are generally not materially affected by seasonality.
For the 12 months ended July 4, 2010, Healthcare, Consumer Lifestyle and Lighting had revenues of EUR 8,115 million, EUR 9,101 million and EUR 7,161 million respectively (12 months ended June 28, 2009: EUR 7,988 million, EUR 9,058 million and EUR 6,839 million respectively) and reported adjusted income from operations of EUR 1,009 million, EUR 734 million and EUR 616 million respectively (12 months ended June 28, 2009: EUR 752 million, a loss of EUR 29 million and a profit of EUR 52 million respectively).
During the first six months of 2010, Philips entered into a number of acquisitions. These acquisitions, both individually and in the aggregate, were deemed immaterial in respect of IFRS disclosure requirements. The acquisitions involved an aggregated purchase price of EUR 11 million and have been accounted for using the purchase method of accounting.
In the first six months of 2010 Philips divested 9.4% of the shares in TPV Technology Ltd. (TPV) and several other minor activities.
The TPV shares were sold on March 9, 2010 to CEIEC Ltd., a Hong Kong-based technology company, for a cash consideration of EUR 98 million. The transaction resulted in a gain of EUR 5 million, which was reported under Results relating to investments in associates.
On March 9, 2010 Philips sold 9.4% of the shares in TPV Technology Ltd. (TPV) to a third party for a cash consideration of EUR 98 million. Philips retained 3.0% of the TPV shares, which were transferred to Other noncurrent financial assets, because Philips was no longer able to exercise significant influence with respect to TPV. Consequently, the carrying amount of Investments in
associates was reduced by EUR 123 million. The transaction resulted in a gain of EUR 5 million, which was recognized under Results relating to investments in associates.
Income tax expense isrecognized based on management's best estimate of the weighted average annual income tax rate expected for the full financial year applied to the pretax income of the interim period. This year's income tax expense is higher, mainly due to higher earnings in 2010 and EUR 95 million of net tax benefits in 2009, including the recognition of a deferred tax asset for Lumileds and a number of tax settlements partly offset by additional liabilities for uncertain tax positions.
During the first six months ended July 4, 2010, there were no significant movements in property, plant and equipment. Apart from currency translation-related differences of EUR 243 million (six months ended June 28, 2009: EUR 18 million), the addition of EUR 305 million (six months ended June 28, 2009: EUR 252 million) was more than offset by depreciation and impairment charges of EUR 324 million (six months ended June 28, 2009: EUR 324 million).
in millions of euros
| Balance as of December 31, 2009 | |
|---|---|
| Cost | 8,021 |
| Amortization / Impairments | (659) |
| Book value | 7,362 |
| Changes in book value: | |
| Acquisitions | 6 |
| Impairments | - |
| Translation differences | 1,221 |
| Balance as of July 4, 2010: | |
| Cost | 9,359 |
| Amortization / Impairments | (770) |
| Book value | 8,589 |
Respiratory Care and Sleep Management and Professional Luminaires remain sensitive to fluctuations in the key assumptions used in the impairment tests as set out below. In addition, Home Monitoring is sensitive to healthcare reform in the United States.
8 Income taxes In 2010, the organizational structure of the Healthcare sector changed, as referenced in note 4. As a result of the change, part of the goodwill of Clinical Care Systems was allocated to Imaging Systems and the other part to Patient Care and Clinical Informatics (former Healthcare Informatics). Furthermore, Respiratory Hospital and related goodwill were transferred to Patient Care and Clinical Informatics. Applicable goodwill balances are reflected in the table below.
For impairment testing, goodwill is allocated to (groups of) cash-generating units (typically one level below sector level), which represent the lowest level at which goodwill is monitored for internal management purposes. A significant part of goodwill is allocated to the following businesses:
| July 4, 2010 | |
|---|---|
| Respiratory Care and Sleep Management | 2,359 |
| Professional Luminaires | 1,608 |
| Imaging Systems | 1,549 |
| Patient Care and Clinical Informatics | 1,409 |
10 Goodwill Key assumptions used in the annual impairment tests (performed in the second quarter) for the businesses in the table above were sales growth rates and the rates used for discounting the projected cash flows. For the 2010 annual test, cash flow projections, reflecting value in use, were determined using management's internal forecasts that cover an initial period from 2010 to 2015 and were extrapolated with stable or declining growth rates for a period of no more than 5 years, after which a terminal value was calculated, for which growth rates were capped at a historical long-term average growth rate.
The projected cash flows rely on the experience of the management teams of the cash-generating units and are based on market growth assumptions and industry longterm growth averages. Cash flow projections of Respiratory Care and Sleep Management, Professional Luminaires, Imaging Systems, and Patient Care and Clinical Informatics for 2010 were based on the following key assumptions:
Income from operations in all four units is expected to increase over the projection period as a result of volume growth and cost efficiencies. The respective pre-tax discount rates applied to the most recent cash flow projections were 10.2%, 14.0%, 11.1% and 12.1% respectively. Based on this analysis, management did not identify impairment for these (groups of) cash-generating units.
The value in use of Respiratory Care and Sleep Management in the annual impairment test was approximately EUR 100 million above its carrying value. An increase of 30 basis points in the pre-tax discount rate, a 50 basis points decrease in the compound long-term sales growth rate, or a 5% decrease in terminal value would cause its value in use to fall to the level of its carrying value.
The value in use of Professional Luminaires in the annual test was approximately EUR 600 million above its carrying value. An increase of 250 basis points in the pre-tax discount rate, a 280 basis points decrease in the compound long-term sales growth rate, or a 34% decrease in terminal value would cause its value in use to fall to the level of its carrying value.
The results of the annual impairment test of Imaging Systems and Patient Care and Clinical Informatics have indicated that a reasonably possible change in key assumptions would not cause the value in use to fall to the level of the carrying value.
| Intangible assets excluding goodwill in millions of euros |
|
|---|---|
| Book value as of December 31, 2009 | 4,161 |
| Changes in book value: | |
| Additions | 194 |
| Acquisitions | 11 |
| Amortization/deductions | (359) |
| Impairment losses | (4) |
| Translation differences | 609 |
| Total changes | 451 |
| Book value as of July 4, 2010 | 4,612 |
The changes during 2010 are as follows:
Other non-current financial assets in millions of euros
| Balance as of December 31, 2009 | 691 |
|---|---|
| Changes: | |
| Reclassifications | 34 |
| Acquisitions/additions | 20 |
| Sales/redemptions/reductions | (15) |
| Value adjustments | − |
| Translation and exchange differences | 34 |
| Balance as of July 4, 2010 | 764 |
Other non-current financial assets mainly consist of available-for-sale financial assets.
Reclassifications relate to the 3.0% retained interest in TPV Technology Ltd. (TPV) which was reclassified from Investmentsin associatessubsequent to the sale of 9.4% of the TPV shares to a third party. For further details, please refer to note 7.
The available-for-sale financial assets include a 19.8% interest in NXP Semiconductors N.V. (NXP) with a carrying value of EUR 207 million. NXP is treated as a cost-method investment.
Triggered by the net losses incurred by NXP, Philips performed impairment reviews on the carrying value of the investment in NXP during the firstsix months of 2010. The impairment review was approached consistent with the methodology outlined in our Annual Report 2009.
In accordance with IAS 39, Financial Instruments: Recognition and Measurement, paragraph 66, if there is objective evidence that an impairment loss has been incurred for an unquoted equity investment carried at cost, the amount of the impairment loss is measured as the difference between the carrying amount of the investment and the present value of the discounted estimated future cash flows.
Based on the impairment reviews performed during the firstsix months of 2010, we concluded that no impairment was necessary.
Inventories are summarized as follows:
| December 31, | July 4, | |
|---|---|---|
| 2009 | 2010 | |
| Raw materials and supplies | 871 | 1,143 |
| Work in progress | 408 | 555 |
| Finished goods | 1,634 | 2,230 |
| 2,913 | 3,928 |
In April 2010, Philips settled a dividend of EUR 0.70 per common share, representing a total value of EUR 650 million. Shareholders could elect for a cash dividend or a share dividend. Around 53.25% of the shareholders elected for a share dividend, resulting in the issuance of 13,667,015 new common shares. The settlement of the cash dividend involved an amount of EUR 304 million.
As of July 4, 2010, the issued and fully paid share capital consists of 986,078,784 common shares, each share having a par value of EUR 0.20.
During the first six months of 2010 a total of 4,187,823 treasury shares were delivered as a result of stock option exercises,restricted share deliveries and other employeerelated share plans. There were no transactions to reduce share capital. On July 4, 2010 the total number of treasury shares amounted to 40,766,854, which were purchased at an average price of EUR 27.02 per share.
13 Inventories At the end of Q2 2010 the total debt position of Philips was EUR 4,799 million, an increase of EUR 533 million compared to December 31, 2009. Long-term debt was EUR 3,053 million, a decrease of EUR 587 million, and short-term debt was EUR 1,746 million, an increase of EUR 1,119 million compared to December 31, 2009. The movement was mainly due to reclassification of oustanding USD and EUR public bondsto short-term debt and currency translation effects. Total remaining longterm debt mainly consisted of outstanding public bonds for a book value of EUR 2,651 million, which were previously issued in USD. The weighted average interest rate of the long-term USD bonds was 5.57% at the end of Q2 2010.
Provisions are summarized as follows:
| Work in progress | 408 | 555 | December 31, | July 4, | ||
|---|---|---|---|---|---|---|
| 2009 | 2010 | |||||
| Finished goods | 1,634 | 2,230 | long short |
long | short | |
| 2,913 | 3,928 | term term |
term | term | ||
| The amounts recorded above are net of allowances for obsolescence. |
Provisions for defined-benefit plans | 669 61 |
686 | 52 | ||
| Other postretirement benefits | 296 21 |
340 | 25 | |||
| Postemployment benefits and | ||||||
| On July 4, 2010, the write-down of inventories to net realizable value amounted to EUR 115 million (year-end 2009: EUR 219 million). The write-down is included in |
obligatory severance payments | 106 29 |
94 | 39 | ||
| Product warranty | 108 227 |
121 | 226 | |||
| Loss contingencies (environmental | ||||||
| remediation and product liability) | 186 14 |
220 | 22 | |||
| cost of sales. | Restructuring-related provisions | 78 318 |
73 | 293 | ||
| Shareholders' equity | Other provisions | 291 46 |
269 | 75 | ||
| 1,734 716 |
1,803 | 732 |
There are no significant changes in provisions compared to year-end 2009.
The increase in accrued liabilities is mainly driven by changes in the fair values of derivatives totaling EUR 774 million.
In accordance with IAS 34, actuarial gains and losses are reported in the semi-annualreport only if there have been significant changes in financial markets. In the first six months of 2010 no actuarial gains or losses were recorded as the changes in financial markets during that period were considered not significant. In the first six months of 2009 the combined effect of actuarial gains and losses and IFRIC 14 was a reduction in equity of EUR 1.8 billion net of tax. For the whole of 2009 the combined effect of actuarial gains and losses and IFRIC 14 was a reduction in equity of EUR 0.9 billion net of tax due to favorable developments in the second half of 2009.
The half-year estimates are limited to the principal plans, i.e. the defined-benefit plans in the Netherlands, Germany, the UK and the US, which together represent more than 90% of the defined-benefit pension assets and liabilities for the Group as a whole. Estimated changes in recognized prepaid pension costs are in accordance with IFRIC 14.
Actuarial gains or losses, if any, are reported under Other comprehensive income and against the respective balance sheet items.
Philips' policy is to provide guarantees and other letters of support only in writing. Philips does not stand by other forms of support. At the end of Q2 2010, the total fair value of guarantees recognized on the balance sheet was EUR 14 million (December 31, 2009: EUR 14 million). Remaining off-balance-sheet business and credit-related guarantees provided to third parties and associates decreased by EUR 3 million during the first half of 2010 to EUR 305 million.
The Company and its subsidiaries are subject to environmental laws and regulations. Underthese laws, the Company and/or its subsidiaries may be required to remediate the effects of the release or disposal of certain chemicals on the environment.
A number of subsidiaries of the Company have been identified for further investigation of possible environmental obligations. In the United States, subsidiaries of the Company have been named as potentially responsible parties in state and federal proceedings for the clean-up of various sites. The Company accrues for losses associated with environmental obligations when such losses are probable and reliably estimable.
The Company and certain of its group companies and former group companies are involved as a party in legal proceedings, including regulatory and other governmental proceedings, including discussions on potential remedial actions, relating to such matters as competition issues, commercial transactions, product liability, participations and environmental pollution. In respect of antitrust laws, the Company and certain of its (former) group companies are involved in investigations by competition law authorities in several jurisdictions and are engaged in litigation in this respect. Since the ultimate disposition of asserted claims and proceedings and investigations cannot be predicted with certainty, an adverse outcome could have a material adverse effect on the Company's consolidated financial position and consolidated results of operations for a particular period. For certain legal proceedings information required under IAS 37 is not disclosed, if the Company concludes that the disclosure can be expected to prejudice seriously the outcome of the legal proceeding.
19 Contingent liabilities For information regarding legal proceedings in which the Company is involved, please refer to our Annual Report 2009. Significant developments regarding legal proceedings that have occurred since the publication of our Annual Report 2009 are described below:
On March 30, 2010, the District Court adopted the Special Master's Report and Recommendation denying the bulk of the motions to dismiss filed on behalf of all Philips entities in response to both the direct and indirect purchaser actions in the federal class actions pending in the Northern District of California. These cases have now proceeded to discovery. The Court has not set a trial date and there is no timetable for the resolution of these cases.
On April 15, 2010, Philips Electronics North America Corporation moved to dismiss the Nokia complaint on the ground that Nokia has failed to state a claim upon which relief can be granted. This motion was granted on June 29, 2010 with leave to amend. Nokia has until July 23, 2010 to amend its complaint.
On April 7, 2010, a class action proceeding was instituted in the Province of Quebec on behalf of all Canadian residents (or alternatively Quebec residents only) who purchased, used and/or received an ODD or purchased any products which contained an ODD, since approximately January 2001 through to the present. The class action named, amongst others, as defendants, Koninklijke Philips Electronics N.V., Philips Electronics North America Corporation, Philips Canada Ltd., Lite-On IT Corporation, Philips & Lite-On Digital Solution Corporation and Philips & Lite-On Digital Solutions USA, Inc. The petitioner seeks both compensatory and punitive damages and all applicable interest, but they have not quantified the value of these damages in their claim.
In the normal course of business, Philips purchases and sells goods and services from/to various related parties in which Philips typically holds a 50% or less equity interest and has significant influence. These transactions are generally conducted with terms comparable to transactions with third parties.
in millions of euros
| January-June | ||||
|---|---|---|---|---|
| 2009 | 2010 | |||
| Purchases of goods and services | 119 | 151 | ||
| Sales of goods and services | 73 | 68 | ||
| Balance outstanding | ||||
| June 28, 2009 | July 4, 2010 | |||
| Receivables from related parties | 13 | 11 | ||
| Payables to related parties | 47 | 13 |
Share-based compensation expense amounted to EUR 29 million and EUR 35 million in the first six months of 2010 and 2009 respectively.
During the first six months of 2010 the Company granted 5,028,436 stock option rights on its common shares and 1,258,122 rights to receive common shares in the future (restricted share rights).
A total of 1,812,948 restricted shares were issued to employees. 686,274 EUR-denominated options and 796,839 USD-denominated options were exercised at a weighted average exercise price of EUR 19.52 and USD 23.88 respectively.
Under the employee stock purchase plans 1,010,624 shares have been purchased at an average price of EUR 21.73.
For further information on the characteristics of these plans, please refer to the Annual Report 2009, note 30.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.